UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 34

Sortiert nach

Interferon-alpha for treating polycythemia vera yields improved myelofibrosis-free and overall survival

Leukemia, 2021-09, Vol.35 (9), p.2592-2601

2021

Link zum Volltext

Verfügbarkeit prüfen

Disease progression in myeloproliferative neoplasms: comparing patients in accelerated phase with those in chronic phase with increased blasts (<10%) or with other types of disease progression

Haematologica (Roma), 2020-05, Vol.105 (5), p.e221

2020

Link zum Volltext

Verfügbarkeit prüfen

Geographic and Temporal Trends in COVID-Associated Acute Kidney Injury in the National COVID Cohort Collaborative

Clinical journal of the American Society of Nephrology, 2023-08, Vol.18 (8), p.1006

2023

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of bone marrow morphology is essential for assessing disease status in recombinant interferon α-treated polycythemia vera patients

Haematologica (Roma), 2017-03, Vol.102 (3), p.e97

2017

Link zum Volltext

Verfügbarkeit prüfen

Kinematic and Kinetic Comparisons of Arm Slot Position Between High School and Professional Pitchers

Orthopaedic journal of sports medicine, 2023-10, Vol.11 (6), p.23259671221147874-23259671221147874

2023

Link zum Volltext

Verfügbarkeit prüfen

Critical Evaluation of Who 2016 Criteria for the Diagnosis of Polycythemia Vera: Distinction from JAK2V617+ Essential Thrombocythemia

Blood, 2017-12, Vol.130, p.4181-4181

2017

Link zum Volltext

Verfügbarkeit prüfen

Unbiased Identification of Thrombosis Risk Factors in Polycythemia Vera (PV) Using Machine Learning and Rich Data from Automated Extraction of Medical Records Generates Dynamic Models Highly Predictive for Thrombosis in PV

Blood, 2022-11, Vol.140 (Supplement 1), p.3961-3962

2022

Link zum Volltext

Verfügbarkeit prüfen

Ruxolitinib can cause weight gain by blocking leptin signaling in the brain via JAK2/STAT3

Blood, 2020-03, Vol.135 (13), p.1062-1066

2020

Link zum Volltext

Verfügbarkeit prüfen

A Novel Machine Learning-Derived Dynamic Scoring System Predicts Risk of Thrombosis in Polycythemia Vera (PV) Patients

Blood, 2021-11, Vol.138 (Supplement 1), p.3619-3619

2021

Link zum Volltext

Verfügbarkeit prüfen

Prevalence and risk factors for Pulmonary Hypertension associated with chronic Myeloproliferative Neoplasms

European journal of haematology, 2021-02, Vol.106 (2), p.250-259

2021

Link zum Volltext

Verfügbarkeit prüfen

Interferon in Polycythemia Vera (PV) Yields Improved Myelofibrosis-Free and Overall Survival

Blood, 2020-11, Vol.136 (Supplement 1), p.31-32

2020

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of Bone Marrowmmorphology in Addition to JAK2 Allele Burden Is Essential for Assessing Disease Status in Recombinant Interferon Alpha-Treated Polycythemia Vera Patients

Blood, 2016-12, Vol.128 (22), p.5471-5471

2016

Link zum Volltext

Verfügbarkeit prüfen

Development of an Automated Tool for Assessing Response in Patients with Polycythemia Vera

Blood, 2018-11, Vol.132 (Supplement 1), p.5462-5462

2018

Link zum Volltext

Verfügbarkeit prüfen

Initial Therapy of Polycythemia Vera (PV) with Interferon Alfa (rIFNa) Compared to Hydroxyurea (HU) or Phlebotomy Only (PHL-O) Is Associated with a Lower Risk of Secondary Myelofibrosis

Blood, 2018-11, Vol.132 (Supplement 1), p.4316-4316

2018

Link zum Volltext

Verfügbarkeit prüfen

Extracting and classifying diagnosis dates from clinical notes: A case study

Journal of biomedical informatics, 2020-10, Vol.110, p.103569-103569, Article 103569

2020

Link zum Volltext

Verfügbarkeit prüfen

Use of Pegylated Interferon in Six Pediatric Patients with Myeloproliferative Neoplasms

Blood, 2019-11, Vol.134 (Supplement_1), p.4194-4194

2019

Link zum Volltext

Verfügbarkeit prüfen

Phase II Trial of SGI-110 (Guadecitabine) in Philadelphia Negative Myeloproliferative Neoplasms

Blood, 2019-11, Vol.134 (Supplement_1), p.1666-1666

2019

Link zum Volltext

Verfügbarkeit prüfen

A Clinical Review of the Co-Occurrence of Myeloproliferative and Lymphoproliferative Neoplasms

Blood, 2018-11, Vol.132 (Supplement 1), p.4285-4285

2018

Link zum Volltext

Verfügbarkeit prüfen

Ruxolitinib Can Lead to Weight Gain in Patients with Myeloproliferative Neoplasms By Uncoupling Feeding from Central Leptin Signaling Via JAK2/STAT3

Blood, 2018-11, Vol.132 (Supplement 1), p.4284-4284

2018

Link zum Volltext

Verfügbarkeit prüfen

Interferon in Polycythemia Vera (PV) Yields Improved Myelofibrosis-Free and Overall Survival

Blood, 2019-11, Vol.134 (Supplement_1), p.2942-2942

2019

Link zum Volltext

Verfügbarkeit prüfen

Recombinant Interferon-α Reduces Thrombotic Events in Patients with Polycythemia Vera

Blood, 2019-11, Vol.134 (Supplement_1), p.1664-1664

2019

Link zum Volltext

Verfügbarkeit prüfen

The influence of stride width on kinematic and kinetics in high school and professional baseball pitchers: A propensity-matched biomechanical evaluation

Journal of science and medicine in sport, 2022-07, Vol.25 (7), p.599-605

2022

Link zum Volltext

Verfügbarkeit prüfen

Comparative Merits of Available Mortality Data Sources for Clinical Research

AMIA ... Annual Symposium proceedings, 2023, Vol.2023, p.634-640

2023

Link zum Volltext

Verfügbarkeit prüfen

Myeloproliferative Neoplasm (MPN) Driver Mutations Are Enriched during Hematopoietic Stem Cell Differentiation in Patterns That Correlate with Clinical Phenotype and Treatment Response

Blood, 2018-11, Vol.132 (Supplement 1), p.4317-4317

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 34

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(33)
Tagungsberichte
(1)

Sprache

Englisch
(34)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Interferon-alpha for treating polycythemia vera yields improved myelofibrosis-free and overall survival

Disease progression in myeloproliferative neoplasms: comparing patients in accelerated phase with those in chronic phase with increased blasts (<10%) or with other types of disease progression

Geographic and Temporal Trends in COVID-Associated Acute Kidney Injury in the National COVID Cohort Collaborative

Evaluation of bone marrow morphology is essential for assessing disease status in recombinant interferon α-treated polycythemia vera patients

Kinematic and Kinetic Comparisons of Arm Slot Position Between High School and Professional Pitchers

Critical Evaluation of Who 2016 Criteria for the Diagnosis of Polycythemia Vera: Distinction from JAK2V617+ Essential Thrombocythemia

Unbiased Identification of Thrombosis Risk Factors in Polycythemia Vera (PV) Using Machine Learning and Rich Data from Automated Extraction of Medical Records Generates Dynamic Models Highly Predictive for Thrombosis in PV

Ruxolitinib can cause weight gain by blocking leptin signaling in the brain via JAK2/STAT3

A Novel Machine Learning-Derived Dynamic Scoring System Predicts Risk of Thrombosis in Polycythemia Vera (PV) Patients

Prevalence and risk factors for Pulmonary Hypertension associated with chronic Myeloproliferative Neoplasms

Interferon in Polycythemia Vera (PV) Yields Improved Myelofibrosis-Free and Overall Survival

Evaluation of Bone Marrowmmorphology in Addition to JAK2 Allele Burden Is Essential for Assessing Disease Status in Recombinant Interferon Alpha-Treated Polycythemia Vera Patients

Development of an Automated Tool for Assessing Response in Patients with Polycythemia Vera

Initial Therapy of Polycythemia Vera (PV) with Interferon Alfa (rIFNa) Compared to Hydroxyurea (HU) or Phlebotomy Only (PHL-O) Is Associated with a Lower Risk of Secondary Myelofibrosis

Extracting and classifying diagnosis dates from clinical notes: A case study

Use of Pegylated Interferon in Six Pediatric Patients with Myeloproliferative Neoplasms

Phase II Trial of SGI-110 (Guadecitabine) in Philadelphia Negative Myeloproliferative Neoplasms

A Clinical Review of the Co-Occurrence of Myeloproliferative and Lymphoproliferative Neoplasms

Ruxolitinib Can Lead to Weight Gain in Patients with Myeloproliferative Neoplasms By Uncoupling Feeding from Central Leptin Signaling Via JAK2/STAT3

Interferon in Polycythemia Vera (PV) Yields Improved Myelofibrosis-Free and Overall Survival

Recombinant Interferon-α Reduces Thrombotic Events in Patients with Polycythemia Vera

The influence of stride width on kinematic and kinetics in high school and professional baseball pitchers: A propensity-matched biomechanical evaluation

Comparative Merits of Available Mortality Data Sources for Clinical Research

Novel Machine Learning Algorithm Predicts Disease Progression in Polycythemia Vera (PV) with Readily-Available Baseline Characteristics

Myeloproliferative Neoplasm (MPN) Driver Mutations Are Enriched during Hematopoietic Stem Cell Differentiation in Patterns That Correlate with Clinical Phenotype and Treatment Response

Suchergebnisse filtern